Pituitary tumor‑transforming gene 1 regulates the senescence and apoptosis of oral squamous cell carcinoma in a p21‑dependent DNA damage response manner
Oncology Reports · 2024
DOI: 10.3892/or.2024.8794 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Reports, 2024. Verfasst von Suyeon Park und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Pathology, College of Dentistry, Gangneung‑Wonju National University, Gangneung‑si, Gangwon‑do 25457, Republic of Korea. Hauptthemen laut MEDLINE: Securin, Mouth Neoplasms, Cellular Senescence, Apoptosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral Pathology, College of Dentistry, Gangneung‑Wonju National University, Gangneung‑si, Gangwon‑do 25457, Republic of Korea.
- Department of Oral and Maxillofacial Surgery, College of Dentistry, Dankook University, Dongnam‑gu, Cheonan 31116, Republic of Korea.
Zitieren
APA
Park, S., Kim, S., Kim, M. Y., Lee, S. S., & Choi, J. (2024). Pituitary tumor‑transforming gene 1 regulates the senescence and apoptosis of oral squamous cell carcinoma in a p21‑dependent DNA damage response manner. Oncology Reports. https://doi.org/10.3892/or.2024.8794
Vancouver
Park S, Kim S, Kim MY, Lee SS, Choi J. Pituitary tumor‑transforming gene 1 regulates the senescence and apoptosis of oral squamous cell carcinoma in a p21‑dependent DNA damage response manner. Oncology Reports. 2024. doi:10.3892/or.2024.8794
BibTeX
@article{Park2024,
author = {Park, Suyeon and Kim, Shihyun and Kim, Moon-Young and Lee, Sang Shin and Choi, Jongho},
title = {Pituitary tumor‑transforming gene 1 regulates the senescence and apoptosis of oral squamous cell carcinoma in a p21‑dependent DNA damage response manner},
journal = {Oncology Reports},
year = {2024},
doi = {10.3892/or.2024.8794}
}
EUVIMED